Antimicrobial susceptibility analysis of isepamicin combination treatments in Mycobacterium abscessus species
Authors:
Open Access
- 15 July 2024
- journal article
- research article
- Published by Elsevier in Journal of Clinical Tuberculosis and Other Mycobacterial Diseases
- Vol. 36, 100464
Abstract
No abstract availableKeywords
Funding Information
- Juntendo University
This publication has 23 references indexed in Scilit:
- The synergetic effect of sitafloxacin–arbekacin combination in the Mycobacterium abscessus speciesScientific Reports, 2023
- A Rough Colony Morphology ofMycobacterium abscessusIs Associated With Cavitary Pulmonary Disease and Poor Clinical OutcomeThe Journal of Infectious Diseases, 2023
- Treatment of Mycobacterium abscessus Pulmonary DiseaseChest, 2022
- Efficacy estimation of a combination of triple antimicrobial agents against clinical isolates of Mycobacterium abscessus subsp. abscessus in vitroJAC-Antimicrobial Resistance, 2021
- Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice GuidelineClinical Infectious Diseases, 2020
- Glycopeptidolipid Genotype Correlates With the Severity of Mycobacterium abscessus Lung DiseaseThe Journal of Infectious Diseases, 2020
- Further isolation of Mycobacterium abscessus subsp. abscessus and subsp. bolletii in different regions of Japan and susceptibility of these isolates to antimicrobial agentsInternational Journal of Antimicrobial Agents, 2013
- Mycobacterium abscessus: a new antibiotic nightmareJournal of Antimicrobial Chemotherapy, 2012
- Identification of antimicrobial activity among FDA-approved drugs for combating Mycobacterium abscessus and Mycobacterium chelonaeJournal of Antimicrobial Chemotherapy, 2011
- The Most Frequent Aminoglycoside Resistance Mechanisms--Changes with Time and Geographic Area: A Reflection of Aminoglycoside Usage Patterns?Clinical Infectious Diseases, 1997